Definitive Healthcare (DH) Competitors $2.53 0.00 (0.00%) Closing price 04/17/2025 04:00 PM EasternExtended Trading$2.54 +0.01 (+0.20%) As of 04/17/2025 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock DH vs. IAS, DAVA, COUR, QUBT, BBAI, BLND, VTEX, DCBO, MOMO, and YALAShould you be buying Definitive Healthcare stock or one of its competitors? The main competitors of Definitive Healthcare include Integral Ad Science (IAS), Endava (DAVA), Coursera (COUR), Quantum Computing (QUBT), BigBear.ai (BBAI), Blend Labs (BLND), VTEX (VTEX), Docebo (DCBO), Hello Group (MOMO), and Yalla Group (YALA). These companies are all part of the "computer software" industry. Definitive Healthcare vs. Integral Ad Science Endava Coursera Quantum Computing BigBear.ai Blend Labs VTEX Docebo Hello Group Yalla Group Integral Ad Science (NASDAQ:IAS) and Definitive Healthcare (NASDAQ:DH) are both small-cap business services companies, but which is the better stock? We will compare the two companies based on the strength of their risk, community ranking, profitability, earnings, institutional ownership, analyst recommendations, valuation, dividends and media sentiment. Do analysts recommend IAS or DH? Integral Ad Science currently has a consensus price target of $14.35, suggesting a potential upside of 120.09%. Definitive Healthcare has a consensus price target of $5.35, suggesting a potential upside of 111.46%. Given Integral Ad Science's stronger consensus rating and higher probable upside, equities analysts plainly believe Integral Ad Science is more favorable than Definitive Healthcare.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Integral Ad Science 0 Sell rating(s) 6 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 2.50Definitive Healthcare 2 Sell rating(s) 7 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.08 Does the media favor IAS or DH? In the previous week, Integral Ad Science had 9 more articles in the media than Definitive Healthcare. MarketBeat recorded 10 mentions for Integral Ad Science and 1 mentions for Definitive Healthcare. Integral Ad Science's average media sentiment score of 0.36 beat Definitive Healthcare's score of -0.50 indicating that Integral Ad Science is being referred to more favorably in the media. Company Overall Sentiment Integral Ad Science Neutral Definitive Healthcare Negative Do insiders & institutionals believe in IAS or DH? 95.8% of Integral Ad Science shares are held by institutional investors. Comparatively, 98.7% of Definitive Healthcare shares are held by institutional investors. 2.0% of Integral Ad Science shares are held by insiders. Comparatively, 14.8% of Definitive Healthcare shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term. Is IAS or DH more profitable? Integral Ad Science has a net margin of 6.39% compared to Definitive Healthcare's net margin of -142.38%. Integral Ad Science's return on equity of 3.47% beat Definitive Healthcare's return on equity.Company Net Margins Return on Equity Return on Assets Integral Ad Science6.39% 3.47% 2.83% Definitive Healthcare -142.38%1.76%1.12% Does the MarketBeat Community favor IAS or DH? Integral Ad Science received 27 more outperform votes than Definitive Healthcare when rated by MarketBeat users. Likewise, 51.00% of users gave Integral Ad Science an outperform vote while only 27.27% of users gave Definitive Healthcare an outperform vote. CompanyUnderperformOutperformIntegral Ad ScienceOutperform Votes5151.00% Underperform Votes4949.00% Definitive HealthcareOutperform Votes2427.27% Underperform Votes6472.73% Which has more risk and volatility, IAS or DH? Integral Ad Science has a beta of 1.53, meaning that its stock price is 53% more volatile than the S&P 500. Comparatively, Definitive Healthcare has a beta of 1.48, meaning that its stock price is 48% more volatile than the S&P 500. Which has higher valuation and earnings, IAS or DH? Integral Ad Science has higher revenue and earnings than Definitive Healthcare. Definitive Healthcare is trading at a lower price-to-earnings ratio than Integral Ad Science, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioIntegral Ad Science$530.10M2.01$7.24M$0.2328.35Definitive Healthcare$252.20M1.13-$202.39M-$3.52-0.72 SummaryIntegral Ad Science beats Definitive Healthcare on 16 of the 18 factors compared between the two stocks. Get Definitive Healthcare News Delivered to You Automatically Sign up to receive the latest news and ratings for DH and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart DH vs. The Competition Export to ExcelMetricDefinitive HealthcarePrepackaged software IndustryComputer SectorNASDAQ ExchangeMarket Cap$285.67M$21.94B$21.42B$7.34BDividend YieldN/A2.03%3.01%4.30%P/E Ratio-0.82105.0439.4917.80Price / Sales1.1316.642,299.4697.74Price / Cash1.6786.0634.6734.64Price / Book0.257.785.653.98Net Income-$202.39M$438.39M$737.25M$247.81M7 Day Performance-2.32%1.02%1.20%1.80%1 Month Performance-8.66%-7.18%-6.40%-6.81%1 Year Performance-64.06%7.01%52,820.63%1.31% Definitive Healthcare Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)DHDefinitive Healthcare1.6974 of 5 stars$2.53flat$5.35+111.5%-64.8%$285.67M$252.20M-0.82970Short Interest ↑IASIntegral Ad Science3.3583 of 5 stars$6.82-3.1%$14.45+111.9%-30.4%$1.12B$530.10M34.10760Analyst ForecastDAVAEndava3.1591 of 5 stars$17.72+1.5%$39.10+120.7%-43.2%$1.05B$759.42M161.0911,900Positive NewsCOURCoursera3.557 of 5 stars$6.20-1.0%$9.83+58.6%-38.3%$992.48M$694.67M-11.911,400Analyst ForecastGap DownQUBTQuantum Computing2.0734 of 5 stars$6.77+4.0%$8.50+25.6%+705.3%$929.15M$373,000.00-23.3430Gap DownBBAIBigBear.ai1.6193 of 5 stars$2.93+2.6%$5.33+82.3%+62.9%$845.35M$158.24M-3.21660Short Interest ↑News CoverageHigh Trading VolumeBLNDBlend Labs2.8207 of 5 stars$3.26-6.2%$4.91+51.0%+28.8%$845.20M$162.02M-9.571,690News CoveragePositive NewsVTEXVTEX3.2567 of 5 stars$4.52-4.1%$8.90+97.1%-32.9%$834.44M$226.71M75.261,730Analyst ForecastShort Interest ↑Gap DownDCBODocebo2.8113 of 5 stars$27.15-2.1%$53.18+95.9%-33.9%$821.94M$216.93M46.81730Analyst ForecastShort Interest ↑News CoverageMOMOHello Group4.3053 of 5 stars$5.54-5.1%$8.25+48.9%-0.4%$802.74M$10.56B5.712,050Positive NewsYALAYalla Group1.4143 of 5 stars$5.00+7.2%N/A+41.8%$791.92M$339.68M6.84630Gap UpHigh Trading Volume Related Companies and Tools Related Companies IAS Alternatives DAVA Alternatives COUR Alternatives QUBT Alternatives BBAI Alternatives BLND Alternatives VTEX Alternatives DCBO Alternatives MOMO Alternatives YALA Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:DH) was last updated on 4/18/2025 by MarketBeat.com Staff From Our PartnersThe first casualty of the 2025 trade warThe headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...Investors Alley | SponsoredHow War with China Could Start in 128 DaysThe clock is ticking. Those who aren't prepared could lose everything. I've identified 43 investments we...Behind the Markets | SponsoredMy prediction is coming trueWe've developed a surprisingly effective way to see which stocks could double during massive shake-ups, by usi...InvestorPlace | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredRead before the next tariff announcementLarry Benedict, the acclaimed "Market Wizard," is calling an emergency briefing now... The same Larry who –...Brownstone Research | SponsoredTrump to unlock 15-figure fortune for America (May 3rd) ?Recently, President Trump decided to kill the coin, for good reason. It now costs 4 cents to make a single pen...Paradigm Press | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Definitive Healthcare Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Definitive Healthcare With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.